These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing 2005-000826-22 4 - weeks, double blind, parallel, randomized study: Comparison of repetitive transcranial magnetic stimulation (rTMS) and venlafaxine (Effectin ER) in the treatment of resistant depressive disorder not-yet-due
Not reported 2009-010625-39 QEEG cordance and EEG connectivity changes after administration of subanesthetic ketamine doses in depressive disorder patients 2012-02-28 due-trials
Not reported 2013-000952-17 The Role of mTOR (Mammalian Target of Rapamycin) Signaling Pathway in the Antidepressive Effect of Ketamine in Patients with Depressive Disorder. Uloha mTOR (mammalian target or rapamycin) signalni... 2015-12-31 due-trials
Reported results 2015-001639-19 The efficacy of transcranial direct current stimulation (tDCS) in the treatment of depression and brain functional changes compared to venlafaxine. Účinnost a funkční změny mozku při léčbě deprese ... 2019-04-24 due-trials
Not reported 2018-001539-39 Clinical and neurobiological predictors of response to ketamine: towards personalized treatment of depression Klinické a neurobiologické prediktory odpovědi na ketamin jako podklad pro personalizov... 2022-04-14 due-trials
Ongoing 2018-004480-31 Psilocybin versus ketamine – fast acting antidepressant strategies in treatment-resistant depression Psilocybin versus ketamin – strategie rychlé antidepresivní odpovědi u deprese rezistentní k léč... not-yet-due
Ongoing 2020-005037-32 Psilocybin - a strategy of rapid antidepressant response in depression comorbid with cancer, a randomized double-blind study with the possibility of entering open extension. Psilocybin – strategie ... not-yet-due